Skip to main content
Clinical Trials/DRKS00027459
DRKS00027459Completed未知

Evaluation of the effectiveness of an online-based support program for the treatment of depression (Novego®) - A randomized controlled trial

IVP Networks GmbH0 sites311 target enrollmentStarted: December 23, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
311

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 75 Years (—)
Sex
All

Inclusion Criteria

  • one of the following diagnoses according to ICD-10 made by specialists or psychotherapists: F32.0, F32.1, F32.2, F32.8, F32.9, F33.0, F33.1, F33.2, F33.8, F33.9, F34.1
  • A sum score on the PHQ-9 at the time of the baseline interview of at least 5 (at least mild expression of depression)
  • informed consent
  • access to the Internet
  • sufficient knowledge of the German language
  • willingness to participate in three anonymous online surveys and willingness to independently use Novego - Depressionen bewältigen®.
  • Patients must be in a stable therapy situation (pharmacotherapy and/or psychotherapy or waiting situation) at least 4 weeks before randomization and should maintain this situation as far as possible during the study period.

Exclusion Criteria

  • the presence of a psychotic or bipolar disorder (lifetime)
  • acute suicidal behavior within the last 4 weeks
  • alcohol or substance dependence within the last 6 months
  • current use of antipsychotics
  • Presence of a serious illness which, in the opinion of the investigator, precludes the patient's participation in the study until the end of the study

Investigators

Sponsor
IVP Networks GmbH

Similar Trials